1. Home
  2. BBDO vs RMD Comparison

BBDO vs RMD Comparison

Compare BBDO & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Bradesco Sa

BBDO

Banco Bradesco Sa

HOLD

Current Price

$3.34

Market Cap

32.3B

Sector

Finance

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$259.01

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBDO
RMD
Founded
1943
1989
Country
Brazil
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
BBDO
RMD
Price
$3.34
$259.01
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
N/A
$291.10
AVG Volume (30 Days)
51.4K
773.4K
Earning Date
02-05-2026
01-29-2026
Dividend Yield
4.76%
0.93%
EPS Growth
47.11
29.59
EPS
0.38
9.77
Revenue
$16,507,289,161.00
$5,257,400,000.00
Revenue This Year
$78.18
$9.85
Revenue Next Year
$7.75
$7.34
P/E Ratio
$9.12
$26.54
Revenue Growth
16.68
9.36
52 Week Low
$1.80
$199.92
52 Week High
$3.31
$293.81

Technical Indicators

Market Signals
Indicator
BBDO
RMD
Relative Strength Index (RSI) 73.01 58.73
Support Level $2.99 $252.77
Resistance Level $3.08 $261.36
Average True Range (ATR) 0.08 6.03
MACD 0.04 1.10
Stochastic Oscillator 96.15 77.87

Price Performance

Historical Comparison
BBDO
RMD

About BBDO Banco Bradesco Sa

Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: